Most quit breakthrough weight-loss drug within a year
A massive Danish study reveals that despite the remarkable weight-loss benefits of semaglutide, more than half of adults without diabetes stop using it within a year. High costs, unpleasant side effects, and underlying medical or psychiatric conditions play major roles in the dropouts. Younger users and men are especially prone to quitting, raising concerns since discontinuation often leads to weight regain.
